Indo Borax and Chemicals Limited to Acquire Controlling Stake in Kronox Lab Sciences

Offer Price: ₹157.27 per share | Total Consideration: ₹150.50 Crores

Reader Takeaway: Investors gain an exit opportunity at a fixed price, while the acquirer shifts control of the firm.

What just happened

Indo Borax and Chemicals Limited has signed a Share Purchase Agreement to acquire 64.26% of Kronox Lab Sciences Limited from its existing promoters for ₹103.22 per share (adjusted to ₹105.87 with consultancy fees). Consequently, a mandatory open offer under SEBI (SAST) Regulations has been triggered to acquire an additional 25.79% of the voting share capital from public shareholders at an offer price of ₹157.27 per share.

Why this matters

This acquisition marks a significant change in control for Kronox Lab Sciences. Upon completion, the current promoter group will reclassify as public shareholders, and Indo Borax will assume sole control of the company. The open offer provides public investors with a clear exit window at the mandated price, supported by an escrow deposit of ₹38 crore already secured by the acquirer.

Participation Details

Public shareholders registered as of September 30, 2026, are eligible to participate. The tendering period is set for October 15, 2026, through October 29, 2026. Bids must be placed via the 'Acquisition Window' on the BSE/NSE platforms. Investors should note that once shares are tendered, they cannot be withdrawn.

Risks to watch

Investors should consider the tax implications of capital gains before deciding whether to tender their shares. Since the offer is not conditional on a minimum acceptance level, the transition will proceed regardless of how many public shareholders participate.

What to track next

The market will closely watch the response from institutional investors and the final completion of the transfer of control. Shareholders are advised to consult their brokers regarding the precise mechanics of bidding within the designated window.